Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

450

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Non-Metastatic Breast Carcinoma

Interventions

OTHER

No intervention

No intervention added by the study

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER